Allergic Bronchopulmonary Aspergillosis Presenting as Pyopneumothorax: Expanding the Clinical Spectrum
Annals of African Medicine · 2025
DOI: 10.4103/aam.aam_452_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of African Medicine, 2025. Verfasst von Jitendra Kumar Saini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Aspergillus fumigatus. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus fumigatus usually seen in asthmatic individuals, with pleural involvement being exceedingly uncommon. We describe a 23-year-old female with poorly controlled asthma who presented with progressive dyspnoea, chest pain, and left pyo-pneumothorax. Imaging demonstrated complete obstruction of the left main bronchus by a mucus plug with evidence of contralateral bronchiectasis. Laboratory evaluation revealed markedly elevated total IgE levels (6351.8 IU/mL) and raised specific IgE and IgG antibodies to A. fumigatus , fulfilling the modified ISHAM diagnostic criteria for ABPA. The patient was managed with systemic corticosteroids and itraconazole, leading to significant symptomatic and radiological improvement, with resolution of the air leak although minimal pleural thickening persisted as sequela. Pleural disease in ABPA is rarely reported, with published cases including effusion, hydropneumothorax, empyema, and pyo-pneumothorax, attributed to immune-mediated pleural inflammation, secondary infections related to therapy, or advanced fibrotic disease. Misdiagnosis as tuberculosis is frequent in endemic regions due to overlapping radiological features, often delaying appropriate therapy. Our case adds to the limited literature by highlighting pyo-pneumothorax as a potential presentation of ABPA, expanding its clinical spectrum beyond the conventional manifestations. The favorable outcome following combined corticosteroid–antifungal therapy reinforces the importance of early recognition and multidisciplinary management to prevent morbidity associated with such complications. Clinicians should remain vigilant when evaluating pleural involvement in asthmatics with elevated IgE and bronchiectasis, as timely diagnosis and targeted treatment can significantly improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Oncology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
- Department of Respiratory Medicine, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
- Department of Pulmonary Medicine, Critical Care and Sleep Medicine, SCB Medical College and Hospital, Cuttack, Odisha, India.
- Department of Respiratory Medicine and Critical Care Medicine, GMC, Chandigarh, India.
- Department of Respiratory Medicine, PD Hinduja Hospital, Mumbai, Maharashtra, India.
Zitieren
APA
Saini, J. K., Abdullah, Y. V., Modi, S., Narasimharao, I. V. P., Joshi, P., & Shastry, S. (2025). Allergic Bronchopulmonary Aspergillosis Presenting as Pyopneumothorax: Expanding the Clinical Spectrum. Annals of African Medicine. https://doi.org/10.4103/aam.aam_452_25
Vancouver
Saini JK, Abdullah YV, Modi S, Narasimharao IVP, Joshi P, Shastry S. Allergic Bronchopulmonary Aspergillosis Presenting as Pyopneumothorax: Expanding the Clinical Spectrum. Annals of African Medicine. 2025. doi:10.4103/aam.aam_452_25
BibTeX
@article{Saini2025,
author = {Saini, Jitendra Kumar and Abdullah, Yasir V and Modi, Shibani and Narasimharao, Ikkurthi V Prem and Joshi, Priyanshi and Shastry, Shashank},
title = {Allergic Bronchopulmonary Aspergillosis Presenting as Pyopneumothorax: Expanding the Clinical Spectrum},
journal = {Annals of African Medicine},
year = {2025},
doi = {10.4103/aam.aam_452_25}
}
EUVIMED